Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 67, Issue 6, Pages 949-957Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-009-0223-z
Keywords
GCSF; LMO4; Stat3; HDAC; Neurons; Ischemia; Cell death; Acetylation
Categories
Funding
- Canadian Institutes of Health Research [179197]
- Heart and Stroke Foundation of Canada [NA6301]
- Heart and Stroke Foundation of Ontario Centre
Ask authors/readers for more resources
Granulocyte colony-stimulating factor (GCSF) is currently in clinical trials to treat neurodegenerative diseases and stroke. Here, we tested whether LIM domain only 4 protein (LMO4), a hypoxia-inducible gene that protects neurons from ischemic injury, could modulate the neuroprotective effect of GCSF. We showed that GCSF treatment acetylates and phosphorylates Stat3, activates expression of a Stat3-dependent anti-apoptotic gene, p27, and increases neuron survival from ischemic injury. LMO4 participates in Stat3 signaling in hepatocytes and associates with histone deacetylase 2 (HDAC2) in cancer cells. In the absence of LMO4, GCSF fails to rescue neurons from ischemic insults. In wild-type neurons, inhibition of HDAC promoted Stat3 acetylation and the antiapoptotic effect of GCSF. In LMO4 null cortical neurons, expression of wild-type but not HDAC-interaction-deficient LMO4 restored GCSF-induced Stat3 acetylation and p27 expression. Thus, our results indicate that LMO4 enhances GCSF-induced Stat3 signaling in neurons, in part by sequestering HDAC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available